MAPT and Mental deterioration: We demonstrated that t‐Tau and p‐Tau in CSF were associated with the rate of cognitive decline in rpAD patients which is in agreement with previous studies,31 and on this basis, we developed novel prognostic indicators based on the ATN framework, which had better performance than using CSF biomarkers alone.